Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin As Induction for Acute Myeloid Leukemia

被引：0
|
作者：
Seddon, Amanda N. [1 ]
Michael, Angela G. [2 ]
Adel, Nelly G. [2 ]
Tallman, Martin S. [2 ]
Akin, Oguz [2 ]
Chaim, Joshua [2 ]
Drill, Esther [2 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia
    Seddon, Amanda N.
    Chaim, Joshua
    Akin, Oguz
    Drill, Esther
    Michael, Angela G.
    Adel, Nelly
    Tallman, Martin S.
    LEUKEMIA RESEARCH, 2018, 68 : 48 - 50
  • [2] CYTARABIN AND DAUNORUBICIN OR IDARUBICIN IN INDUCTION THERAPY OF ACUTE MYELOID LEUKEMIA PATIENTS
    Eivazi-Ziaei, Jamal
    Kermani, Iraj Asvadi
    Nikanfar, Alireza
    Maljaie, Hadi
    Mahmoudpour, Ali
    Dolatkhah, Roya
    Golchin, Mehri
    Vaez, Jalil
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2009, 25 (05) : 829 - 832
  • [3] Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemia
    Trifilio, Steven
    Zhou, Zheng
    Mehta, Jayesh
    Czerniak, Colleen
    Pi, Judy
    Greenberg, Deborah
    Koslosky, Molly
    Pantiru, Mihaela
    Altman, Jessica
    LEUKEMIA RESEARCH, 2013, 37 (08) : 868 - 871
  • [4] Predictors in the assignment of the daunorubicin doses to the induction chemotherapy in the acute myeloid leukemia
    Yamile, Quintero
    Carlos, Hernandez
    Yusleidy, Concepcion
    Adrian, Romero
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S11 - S12
  • [5] Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia
    Uchida, Mayako
    Mochizuki, Erika
    Ishida, Shigeru
    Ozawa, Nana
    Yonemitsu, Hiroko
    Ochiai, Hideki
    Nakamura, Hanae
    Kawashiri, Takehiro
    Kato, Koji
    Egashira, Nobuaki
    Akashi, Koichi
    Ieiri, Ichiro
    IN VIVO, 2023, 37 (02): : 924 - 932
  • [6] CYTARABINE PLUS IDARUBICIN OR DAUNORUBICIN AS INDUCTION AND CONSOLIDATION THERAPY FOR PREVIOUSLY UNTREATED ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    WIERNIK, PH
    BANKS, PLC
    CASE, DC
    ARLIN, ZA
    PERIMAN, PO
    TODD, MB
    RITCH, PS
    ENCK, RE
    WEITBERG, AB
    BLOOD, 1992, 79 (02) : 313 - 319
  • [7] A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia
    Lee, Je-Hwan
    Kim, Hawk
    Joo, Young-Don
    Lee, Won Sik
    Bae, Sung Hwa
    Zang, Dae Young
    Kwon, Jihyun
    Kim, Min Kyoung
    Lee, Junglim
    Lee, Gyeong Won
    Lee, Jung-Hee
    Choi, Yunsuk
    Kim, Dae-Young
    Lim, Sung-Nam
    Lee, Sang-Min
    Ryoo, Hun-Mo
    Kim, Hyo Jung
    Hyun, Myung Soo
    Lee, Kyoo-Hyung
    BLOOD, 2015, 126 (23)
  • [8] Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression
    Shi, Pengcheng
    Zha, Jie
    Guo, Xutao
    Chen, Feili
    Fan, Zhiping
    Huang, Fen
    Meng, Fanyi
    Liu, Xiaoli
    Feng, Ru
    Xu, Bing
    PHARMACOGENOMICS, 2013, 14 (01) : 17 - 23
  • [9] Typhlitis complicating induction therapy in adult acute myeloid leukemia
    Pastore, D
    Specchia, G
    Mele, G
    Montagna, MT
    Margari, A
    Carluccio, P
    Nacchiero, M
    Liso, V
    LEUKEMIA & LYMPHOMA, 2002, 43 (04) : 911 - 914
  • [10] Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine
    Wiedower, Eric
    Jamy, Omer
    Martin, Michael G.
    ANTICANCER RESEARCH, 2015, 35 (11) : 6287 - 6290
12345